Novartis Investing Big in Austrian Generics Plant
Novartis Investing Big in Austrian Generics Plant
GALWAY, IRELAND--August 11, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis is to expand its Kundl antibiotics facility following a deal with the Austrian government that will see an investment of 150 million euro ($176 million).
Within this article: Details new plant investment, proposed works, antibiotics production in Europe, industry support for new antibiotics research
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Russia Taps Italy to Manufacture Sputnik V COVID-19 Vaccine
- Novartis To Make Pfizer/BioNTech COVID-19 Vaccine in Slovenia
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...